Literature DB >> 19878356

PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.

Min En Nga1, Nu Nu Ma Swe, Kang Ting Chen, Liang Shen, Michael B Lilly, Siew Pang Chan, Manuel Salto-Tellez, Kakoli Das.   

Abstract

The differential diagnosis of soft tissue tumours poses a considerable challenge for pathologists, especially adipocytic tumours, as these may show considerable overlap in clinical presentation and morphological features with many other mesenchymal neoplasms. Hence, a specific and reliable marker that identifies adipocytic differentiation is much sought. We investigated the immunohistochemical expression of PIM-1 kinase in 35 samples of soft tissue tumours using tissue microarray technology and 49 full sections of adipocytic (n = 26) and non-adipocytic tumours (n = 23). Benign and malignant adipocytic tumours showed strong expression of PIM-1 while the non-adipocytic tumours were either negative or showed only weak staining for the protein. In myxoid liposarcomas, PIM-1 showed a distinct, unique vacuolar staining pattern, clearly outlining fine cytoplasmic lipid vacuoles. By contrast, non-adipocytic myxoid tumours (myxoma, chordoma and myxoid chondrosarcoma) did not show this vacuolar pattern of PIM-1 staining, although vacuolated cells were present on H&E. This differential expression was confirmed at a gene expression level in selected cases. Our results indicate that the expression of PIM-1 in adipose tissue may be a useful marker of adipocytic differentiation, in particular if the staining is both of high intensity and present in a unique, vacuolar pattern.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878356      PMCID: PMC2812726          DOI: 10.1111/j.1365-2613.2009.00673.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  39 in total

1.  Microsatellite instability in colorectal cancer: considerations for molecular diagnosis and high-throughput screening of archival tissues.

Authors:  Manuel Salto-Tellez; Soo Chin Lee; Lily L Chiu; Chi Kuen Lee; May Chin Yong; Evelyn S C Koay
Journal:  Clin Chem       Date:  2004-06       Impact factor: 8.327

2.  Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

Authors:  J M Coindre; P Terrier; N B Bui; F Bonichon; F Collin; V Le Doussal; A M Mandard; M O Vilain; J Jacquemier; H Duplay; X Sastre; C Barlier; M Henry-Amar; J Macé-Lesech; G Contesso
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

3.  Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

Authors:  M van Lohuizen; S Verbeek; P Krimpenfort; J Domen; C Saris; T Radaszkiewicz; A Berns
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

4.  Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias.

Authors:  F Dreyfus; B Sola; S Fichelson; P Varlet; M Charon; P Tambourin; F Wendling; S Gisselbrecht
Journal:  Leukemia       Date:  1990-08       Impact factor: 11.528

5.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation.

Authors:  T Goffman; Z Tochner; E Glatstein
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

Review 7.  Transgenic mice as a means to study synergism between oncogenes.

Authors:  A Berns; M Breuer; S Verbeek; M van Lohuizen
Journal:  Int J Cancer Suppl       Date:  1989

8.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.

Authors:  S Verbeek; M van Lohuizen; M van der Valk; J Domen; G Kraal; A Berns
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

10.  Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro.

Authors:  Alessio Zippo; Alessandra De Robertis; Monia Bardelli; Federico Galvagni; Salvatore Oliviero
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  9 in total

1.  Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.

Authors:  Wei Wang; Shuai Han; Wei Gao; Yuan Feng; Kunhang Li; Di Wu
Journal:  Cell Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.046

Review 2.  Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.

Authors:  Ying-Yi Li; Naofumi Mukaida
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  The role of PIM1/PIM2 kinases in tumors of the male reproductive system.

Authors:  Manuel Pedro Jiménez-García; Antonio Lucena-Cacace; María José Robles-Frías; Maja Narlik-Grassow; Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

4.  AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes.

Authors:  Yu-Kyoung Park; Brice Wilfried Obiang-Obounou; Kyung-Bok Lee; Jong-Soon Choi; Byeong-Churl Jang
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

5.  Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation.

Authors:  Ran-Ran Ding; Jian-Ling Yuan; Ya-Nan Jia; Xiao-Min Liao; Si-Si Wang; Zhong-Ming Shao; Mu-Yin Feng; Wei Jie; Zhi-Hua Shen
Journal:  Onco Targets Ther       Date:  2019-02-11       Impact factor: 4.147

6.  Pim1 knockout alleviates sarcopenia in aging mice via reducing adipogenic differentiation of PDGFRα+ mesenchymal progenitors.

Authors:  Guo-Kai Shang; Lu Han; Zhi-Hao Wang; Ming Song; Di Wang; Yan-Min Tan; Yi-Hui Li; Yu-Lin Li; Wei Zhang; Ming Zhong
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-08-25       Impact factor: 12.910

Review 7.  The Role of PIM Kinases in Pediatric Solid Tumors.

Authors:  Janet Rae Julson; Raoud Marayati; Elizabeth Ann Beierle; Laura Lee Stafman
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

8.  Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy.

Authors:  Zhaohuai Li; Mei Wang; Jia Tan; Lei Zhu; Peng Zeng; Xiaozhen Chen; Lihui Xie; Runping Duan; Binyao Chen; Tianyu Tao; Rong Wang; Xianggui Wang; Wenru Su
Journal:  Cell Rep Med       Date:  2022-07-26

9.  Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.

Authors:  Maja Narlik-Grassow; Carmen Blanco-Aparicio; Yolanda Cecilia; Marco Perez; Sandra Muñoz-Galvan; Marta Cañamero; Oliver Renner; Amancio Carnero
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.